Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Clinical trial NCT01522768 · COMPLETED
Trial details
- NCT number
- NCT01522768
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2023-02-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.